GSA appreciates the work of KAER Brain Health Expert Advisory Panel members for their review of and contributions to this edition of the toolkit. The 2024 KAER Brain Health Expert Advisory members include:

  • Amy Boehm, Senior Health Systems Director, Alzheimer's Association
  • Soo Borson, MD, Co-lead, BOLD Public Health Center of Excellence on Early Detection of Dementia; Professor of Clinical Family Medicine, USC Keck School of Medicine; Professor Emerita, Psychiatry and Behavioral Sciences, University of Washington School of Medicine
  • Carolyn K. Clevenger, DNP, GNP-BC, FAANP, FGSA, FAAN, Professor, Nell Hodgson Woodruff School of Nursing at Emory University​; Clinical Director​, Emory Integrated Memory Care​
  • Daphne Delgado, MPH, Vice President, Health Equity, UsAgainstAlzheimer's
  • Sherry A. Greenberg, PhD, RN, GNP-BC, FGSA, FNAP, AGSF, FAANP, FAAN, Evelyn Lauder Chair in Adult Gerontology and Professor, Specialty Director, Adult-Gerontology Primary Care Nurse Practitioner Program, Hunter-Bellevue School of Nursing
  • Frederick Ketchum, MD, PhD, Assistant Professor​, Department of Neurology, University of Wisconsin, School of Medicine and Public Health​
  • Ian Kremer, Executive Director, LEAD Coalition
  • Jim Mangi, Founder, Board President & Care Partner, Dementia Friendly Services
  • Laura Medders, LCSW, Administrative Director​, Emory Integrated Memory Care​
  • Kemi Reeves, DNP, MBA, GNP-BC, Associate Director, UCLA Alzheimer's and Dementia Care Program, Division of Geriatrics, David Geffen School of Medicine at UCLA; Director of Nursing Health Care Equity, Office of Health Equity and Inclusive Excellence, UCLA Health System
  • Anna Satake PhD, MSN, GCNS, RN, Geriatric Clinical Nurse Specialist, Healthy Aging Clinic Midtown; Assistant Clinical Professor, Betty Irene Moore School of Nursing at UC Davis
  • Katie Selzler, PhD, Medical Affairs & Scientific Communications Lead​, Davos Alzheimer's Collaborative Health Systems Preparedness​
  • Mike Splain, Principle, Splain Consulting

GSA is grateful to Katie Maslow, MSW; Richard Fortinsky, PhD; and the members of the GSA Workgroup on Cognitive Impairment Detection and Earlier Diagnosis for their contributions to the first edition of the GSA KAER Toolkit. GSA would also like to acknowledge Eli Lilly and Company for their support of the first edition.


This updated edition was prepared by Judy Crespi-Lofton, MS, in consultation with GSA staff members Karen Tracy, Vice President, Strategic Alliances and Integrated Communications and Jen Pettis, MS, RN, CNE, Director, Strategic Alliances.


Support provided by Eisai, Genentech, Lilly, and Otsuka.